肿瘤基因治疗作为一种全新的肿瘤治疗方法,已从实验室进入临床试用阶段。欧美发达国家竞相在该领域投入大量的人力、物力,涉及黑色素瘤、肾癌、脑瘤、卵巢癌、神经母细胞瘤和肺癌等肿瘤的治疗。国内有关综述多停留在动物实验水平,故有必要针对2年来的肿瘤基因治疗实践做一回顾。 As a new method of tumor treatment, tumor gene therapy has entered the clinical trial phase from the laboratory. Developed countries in Europe and the United States are competing to invest a lot of manpower and material resources in this field, involving melanoma, kidney cancer, brain tumor, ovarian cancer, neuroblastoma, and lung cancer. Domestic review mostly stays at the level of animal experiments, so it is necessary to make a review of the two-year cancer gene therapy practice.